Author

W. Megchelenbrink

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Research Focus:clustering· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

H. G. Stunnenberg· 2 shared P. Brazda· 2 shared A. Dolnik· 1 shared C. Ruiz-Moreno· 1 shared H. Dohner· 1 shared H. J. L. M. Timmers· 1 shared J. Martens· 1 shared K. Dohner· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

H. G. Stunnenberg

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Extensive patient-to-patient single nuclei transcriptome heterogeneity in pheochromocytomas and paragangliomas

P. Brazda, C. Ruiz-Moreno, W. Megchelenbrink, H. J. L. M. Timmers, H. G. Stunnenberg

This study identifies extensive transcriptome heterogeneity in pheochromocytomas and paragangliomas using snRNA-seq, revealing distinct transcriptional programs and developmental arrest stages.

bioRxiv · May 5, 2022Cancer Biology

Longitudinal single-cell transcriptomics reveals distinct patterns of recurrence in acute myeloid leukemia

Y. Zhai, P. Singh, A. Dolnik, P. Brazda, N. Atlasy, N. del Gaudio, K. Dohner, H. Dohner, S. Minucci, J. Martens, L. Altucci, W. Megchelenbrink, L. Bullinger, H. G. Stunnenberg

This study uses longitudinal single-cell transcriptomics to analyze AML recurrence patterns, finding varying transcriptional changes between diagnosis and relapse that challenge the clonal evolution model.

bioRxiv · Jan 4, 2022 · PreprintCancer Biology